TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome - Stanley, Takara L.; Zanni, Markella V.; Johnsen, Stine; Rasheed, Sarah; Makimura, Hideo; Lee, Hang; Khor, Victor K.; Ahima, Rexford S.; Grinspoon, Steven K. (The journal of clinical endocrinology and metabolism, 2011)
Keywords: Adipokines - blood; Adiponectin; Adipose tissue; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; biomarkers; Biomarkers - blood; Biopsy; Blood; Blood Glucose; Body Composition; C-reactive protein; Cell adhesion molecules; Etanercept; Fasting; Female; Gene expression; Glucose; Glucose tolerance; Glucose Tolerance Test; Homeostasis; Hormones; Humans; Immunoglobulin G - therapeutic use; Inflammation; Insulin; Insulin resistance; Intercellular adhesion molecule 1; Interleukin 6; Lipids; Male; Measurement; Metabolic disorders; Metabolic rate; Metabolic syndrome; Metabolic Syndrome - blood; Metabolic Syndrome - complications; Metabolic Syndrome - therapy; Molecular weight; Obesity; Obesity - blood; Obesity - complications; Obesity - therapy; Objectives; Original; Placebos; Protein composition; Proteins; Receptors, Tumor Necrosis Factor - therapeutic use; Subcutaneous Fat - metabolism; Treatment Outcome; Tumor necrosis factor receptors; Tumor necrosis factor- alpha; Tumor necrosis factor-α; Vascular cell adhesion molecule 1; Weight